CARVE™
CARVE™: Continued Access Reinforced by Value Evidence
Proprietary strategic platform developed to address the increasing payer needs for evidence-based access (such as pay for performance, outcomes-based contracting), and provides contracting strategies to optimize or maintain access
- CARVE™ generates real-world evidence to support product’s clinical and/or economic benefits to enhance value / support price
- CARVE™ is a platform which assesses existing Payer value drivers and needs, product(s) positioning, and evidence repository (product and competitors) to support existing contracting strategies
- Best ROI strategies to modify existing evidence generation strategies and/or contracting models
- Supports needs for alternative contracting models which align with Payer needs while supporting EvGen plans for executing and monitoring
How Can CARVE™ Help?
The CARVE™ tool helps a manufacturer manage alternative access contracts given market forces such as Payer evaluation of access renewal, competitive threats, generic/biosimilar availability, etc.
